Literature DB >> 20502171

Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies.

Michael L Bentley1, Howard L Corwin, Joseph Dasta.   

Abstract

Acute kidney injury is common in critically ill patients, with an incidence of 20% to 30%. It has been associated with increased mortality, hospital length of stay, and total cost. A number of strategies may be beneficial in identifying at-risk patients. In addition, using preventive measures and avoiding nephrotoxic medications are paramount in reducing the overall incidence. Although multifactorial, drug-induced acute kidney injury may account for up to 25% of all cases of acute kidney injury in this population. This review focuses on the mechanisms of drug-induced acute kidney injury in critically ill adults and offers preventive strategies when appropriate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20502171     DOI: 10.1097/CCM.0b013e3181de0c60

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

Review 1.  Drug-induced acute kidney injury in children.

Authors:  Lauren N Faught; Michael J E Greff; Michael J Rieder; Gideon Koren
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

2.  Approaches to the Management of Acute Kidney Injury in Children.

Authors:  Rajit K Basu; Derek S Wheeler
Journal:  Recent Pat Biomark       Date:  2011

3.  Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Authors:  Taylor M Patek; Chengwen Teng; Kaitlin E Kennedy; Carlos A Alvarez; Christopher R Frei
Journal:  Drug Saf       Date:  2020-01       Impact factor: 5.606

4.  Endogenous Toll-Like Receptor 9 Regulates AKI by Promoting Regulatory T Cell Recruitment.

Authors:  Maliha A Alikhan; Shaun A Summers; Poh Y Gan; Amy J Chan; Mary B Khouri; Joshua D Ooi; Joanna R Ghali; Dragana Odobasic; Michael J Hickey; A Richard Kitching; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2015-06-26       Impact factor: 10.121

5.  Adverse drug events in an intensive care unit of a university hospital.

Authors:  Adriano Max Moreira Reis; Silvia Helena De Bortoli Cassiani
Journal:  Eur J Clin Pharmacol       Date:  2011-01-19       Impact factor: 2.953

6.  Predicting Major Adverse Kidney Events among Critically Ill Adults Using the Electronic Health Record.

Authors:  Andrew C McKown; Li Wang; Jonathan P Wanderer; Jesse Ehrenfeld; Todd W Rice; Gordon R Bernard; Matthew W Semler
Journal:  J Med Syst       Date:  2017-08-31       Impact factor: 4.460

7.  Adverse drug events during AKI and its recovery.

Authors:  Zachary L Cox; Allison B McCoy; Michael E Matheny; Gautam Bhave; Neeraja B Peterson; Edward D Siew; Julia Lewis; Ioana Danciu; Aihua Bian; Ayumi Shintani; T Alp Ikizler; Erin B Neal; Josh F Peterson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

8.  Renal histoarchitectural changes in nevirapine therapy: possible role of kolaviron and vitamin C in an experimental animal model.

Authors:  Ugochukwu Offor; Sunday Adelaja Ajayi; Isaac Ayoola Jegede; Salem Kharwa; Edwin Coleridge Naidu; Onyemaechi Okpara Azu
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

Review 9.  The multifaceted role of the renal microvasculature during acute kidney injury.

Authors:  Katherine Maringer; Sunder Sims-Lucas
Journal:  Pediatr Nephrol       Date:  2015-10-22       Impact factor: 3.714

10.  Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study.

Authors:  Cynthia M Cely; Roland M H Schein; Andrew A Quartin
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.